CFM
NEO icon

Catalyst Funds Management’s NeoGenomics NEO Stock Holding History

Catalyst Funds Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,000
Closed -$29.5K – 927
2024
Q3 		$29.5K Buy
2,000
+1,600
+400% +$25K 0.01% 988
2024
Q2 		$5.55K Sell
400
-200
-33% -$2.83K ﹤0.01% 1048
2024
Q1 		$9.43K Buy
+600
New +$9.26K ﹤0.01% 893

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Catalyst Funds Management's NEO Position: Q4 2024 in Review

Catalyst Funds Management sold out of NeoGenomics (NEO) in Q4 2024, closing a stake of 2,000 shares — an estimated $29.5K sold.

Catalyst Funds Management first reported a position in NEO in Q1 2024 and held it in 3 quarters. The position peaked at $29.5K in Q3 2024. 253 funds tracked by Wall St. Rank hold NEO as of Q4 2024.

  • Catalyst Funds Management reported no remaining NeoGenomics position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 2,000 NeoGenomics shares in Q4 2024, an estimated $29.5K.
  • Catalyst Funds Management first reported a position in NeoGenomics in Q1 2024 and held it in 3 quarters.
  • Catalyst Funds Management's NeoGenomics position peaked at $29.5K in Q3 2024.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.